Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a ...

A new study finds the worrisome rise in colorectal cancer deaths among younger adults is concentrated in people with less ...

A new study highlights an environmental risk factor that could be driving early onset lung cancer rates. Natalia ...

Simeon Greene, from Wolverhampton, believes 54 of his relatives may have had prostate cancer.

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

Asking Eric: Friend was invited to stay, now is being sent a bill Apr. 15, 2026, 7:00 a.m. With these conversations, it’s ...

South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...

The average age for an ovarian cancer diagnosis is after 63 ...

When James Eddleston found a lump near his nipple it never crossed his mind that it could be breast cancer. "I felt like it ...